Blog Flex Databases

August 25, 2026

How Flex Databases’ Review and Merge Tool Transforms Pharmacovigilance Case Processing

Every pharmacovigilance case tells an evolving story. A case rarely arrives once and stays static – new information keeps surfacing after the initial intake: a patient is hospitalized, a birth date gets corrected, a new reaction is reported, a concomitant medication comes to light.

Learn more→

July 15, 2026

How ITS Cut Manual Safety Tracking by 60% and Strengthened PV Oversight Across Clinical Trials

Integrated Therapeutic Solutions (ITS) is a clinical research organization conducting multi-country clinical trials and supporting post-marketing needs across a growing sponsor portfolio.

Learn more→

September 30, 2025

Subject Tracking & Invoicing – Data Import Wizard.

Cross-site budget setup can turn into hours of manual per-subject cost entry, slowing teams down and creating error risks. With Flex Databases’ Subject Tracking & Invoicing, you can now import Per Subject Costs directly from Excel using the Data Import Wizard.

Learn more→

August 14, 2025

Key Changes to EU Pharmacovigilance Regulation: What You Need to Know

In July 2025, the European Commission adopted Commission Implementing Regulation (EU) 2025/1466, amending Regulation (EU) No 520/2012. The changes aim to strengthen pharmacovigilance, reduce unnecessary administrative burden, and align EU requirements with global best practices.

Learn more→

February 6, 2025

Palobiofarma Chooses Flex Databases for Pharmacovigilance Management

Palobiofarma is a leading clinical-stage biotech company dedicated to developing innovative medicines. Our focus on adenosine signaling drives our commitment to scientific excellence, with six drug candidates currently in different phases of development.

Learn more→

November 19, 2024

How to Choose Pharmacovigilance (PV) Software for Clinical Trial Management

Pharmacovigilance (PV) is a critical aspect of drug safety, focusing on detecting, assessing, understanding, and preventing adverse drug reactions or other drug-related problems.

Learn more→

March 21, 2023

Manage multi-lingual cases within a single instance with Flex Databases Pharmacovigilance

If you operate globally, you must comply with local language requirements, which also apply to pharmacovigilance reporting. Imagine that you must manage cases & report in English, Spanish, and French. How would you do that?

Learn more→

February 27, 2023

Three big questions AI helps to answer in drug development process

There are three big questions in any industry, including pharmaceuticals & clinical trials: Artificial intelligence is one of the new answers to all of them. Here are a few examples:

Learn more→

October 5, 2022

Flex Databases recognised as one of top-10 Pharmacovigilance providers in the UK & Europe

This September, Pharma Tech Outlook included Flex Databases in Top-10 Pharmacovigilance solutions providers in the UK & Europe. Our Business Development & Marketing Director Evgenia Mikhalchuk took part in a cover story for Pharma Tech Outlook September’22 issue, supporting our nomination:

Learn more→

April 28, 2022

Answering 6 most frequently asked questions about Flex Databases Pharmacovigilance module

Each step of Flex Databases is always done with one thought in mind – to save time and money for our clients. That’s why to save your time and give you a deeper understanding of how our Pharmacovigilance module work, we are happy to answer the six most frequently asked questions about the system.

Learn more→

April 21, 2022

Synchronizing safety data from EDC/eCRF with Flex Databases Pharmacovigilance

Many years since the appearance of different platforms and systems for clinical trial operations, there has been a question about making all the systems work synchronized.

Learn more→

October 15, 2021

Challenges of pharmacovigilance automation

The development of information technology is significantly ahead of the development of regulatory and other legislation. Despite the obvious benefits of introducing new technologies in electronic systems for pharmacovigilance, it is necessary to consider the difficulties that a company will face:

Learn more→